111 related articles for article (PubMed ID: 6479461)
1. Inhibition of fibronectin binding to matrix components by nonenzymatic glycosylation.
Cohen MP; Ku L
Diabetes; 1984 Oct; 33(10):970-4. PubMed ID: 6479461
[TBL] [Abstract][Full Text] [Related]
2. Nonenzymatic glycation of fibronectin and alterations in the molecular association of cell matrix and basement membrane components in diabetes mellitus.
Tarsio JF; Wigness B; Rhode TD; Rupp WM; Buchwald H; Furcht LT
Diabetes; 1985 May; 34(5):477-84. PubMed ID: 3987974
[TBL] [Abstract][Full Text] [Related]
3. Acylation of gelatin-agarose and the enhancement by heparin of fibronectin binding.
Smith RL; Griffin CA
Arch Biochem Biophys; 1988 Oct; 266(1):181-8. PubMed ID: 3178220
[TBL] [Abstract][Full Text] [Related]
4. Fibronectin glycosylation modulates fibroblast adhesion and spreading.
Jones GE; Arumugham RG; Tanzer ML
J Cell Biol; 1986 Nov; 103(5):1663-70. PubMed ID: 2946699
[TBL] [Abstract][Full Text] [Related]
5. Complexing of fibronectin glycosaminoglycans and collagen.
Ruoslahti E; Engvall E
Biochim Biophys Acta; 1980 Aug; 631(2):350-8. PubMed ID: 7407251
[TBL] [Abstract][Full Text] [Related]
6. Studies of extracellular fibronectin matrix formation with fluoresceinated fibronectin and fibronectin fragments.
Chernousov MA; Metsis ML; Koteliansky VE
FEBS Lett; 1985 Apr; 183(2):365-9. PubMed ID: 3921405
[TBL] [Abstract][Full Text] [Related]
7. Decreased interaction of fibronectin, type IV collagen, and heparin due to nonenzymatic glycation. Implications for diabetes mellitus.
Tarsio JF; Reger LA; Furcht LT
Biochemistry; 1987 Feb; 26(4):1014-20. PubMed ID: 3567152
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin.
Jalkanen S; Jalkanen M
J Cell Biol; 1992 Feb; 116(3):817-25. PubMed ID: 1730778
[TBL] [Abstract][Full Text] [Related]
9. The heparin III-binding domain of fibronectin (III4-5 repeats) binds to fibronectin and inhibits fibronectin matrix assembly.
Maqueda A; Moyano JV; Hernández Del Cerro M; Peters DM; Garcia-Pardo A
Matrix Biol; 2007 Oct; 26(8):642-51. PubMed ID: 17611093
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of heparin-binding ability of fibronectin by S-carboxamide-methylation.
Kohama Y; Miyamoto T; Oka H; Yamamoto K; Murayama N; Tsujikawa K; Okabe M; Mimura T
J Pharmacobiodyn; 1989 Oct; 12(10):626-33. PubMed ID: 2630632
[TBL] [Abstract][Full Text] [Related]
11. Developmental changes in the glycosylation and binding properties of human fibronectins. Characterization of the glycan structures and ligand binding of human fibronectins from adult plasma, cord blood and amniotic fluid.
Köttgen E; Hell B; Müller C; Kainer F; Tauber R
Biol Chem Hoppe Seyler; 1989 Dec; 370(12):1285-94. PubMed ID: 2619923
[TBL] [Abstract][Full Text] [Related]
12. A weaker gelatin-binding affinity and increased glycosylation of amniotic fluid fibronectin than plasma fibronectin.
Yamaguchi Y; Isemura M; Yosizawa Z; Kan M; Sato A
Int J Biochem; 1986; 18(5):437-43. PubMed ID: 3709931
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of fibronectin matrix assembly by the heparin-binding domain of vitronectin.
Hocking DC; Sottile J; Reho T; Fässler R; McKeown-Longo PJ
J Biol Chem; 1999 Sep; 274(38):27257-64. PubMed ID: 10480945
[TBL] [Abstract][Full Text] [Related]
14. Circulating complexes containing IgA and fibronectin in patients with primary IgA nephropathy.
Cederholm B; Wieslander J; Bygren P; Heinegård D
Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4865-8. PubMed ID: 3387443
[TBL] [Abstract][Full Text] [Related]
15. Amino acid sequence of HSP-1, a major protein of stallion seminal plasma: effect of glycosylation on its heparin- and gelatin-binding capabilities.
Calvete JJ; Mann K; Schäfer W; Sanz L; Reinert M; Nessau S; Raida M; Töpfer-Petersen E
Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):615-22. PubMed ID: 7654203
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms in basement membrane complications of diabetes. Alterations in heparin, laminin, and type IV collagen association.
Tarsio JF; Reger LA; Furcht LT
Diabetes; 1988 May; 37(5):532-9. PubMed ID: 3360214
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of binding of fibronectin to matrix assembly sites by anti-integrin (alpha 5 beta 1) antibodies.
Fogerty FJ; Akiyama SK; Yamada KM; Mosher DF
J Cell Biol; 1990 Aug; 111(2):699-708. PubMed ID: 2380248
[TBL] [Abstract][Full Text] [Related]
18. Diminished adhesion of endothelial aortic cells on fibronectin and collagen layers after nonenzymatic glycation.
Krantz S; Lober M; Thiele M; Teuscher E
Exp Clin Endocrinol; 1988 May; 91(2):155-60. PubMed ID: 3409968
[TBL] [Abstract][Full Text] [Related]
19. Binding of fibronectin to gelatin and heparin: effect of surface denaturation and detergents.
Haas R; Culp LA
FEBS Lett; 1984 Sep; 174(2):279-83. PubMed ID: 6468662
[TBL] [Abstract][Full Text] [Related]
20. Causal relationship between conformational change and inhibition of domain functions of glycoxidative fibronectin.
Sakata N; Sasatomi Y; Ando S; Meng J; Imanaga Y; Uesugi N; Takebayashi S
Connect Tissue Res; 2000; 41(2):117-29. PubMed ID: 10992158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
